Post-HCT outcomes for 935 adults with AML undergoing allogeneic HCT while in first or second morphologic remission, stratified by pre-HCT/day +70 to +100 post-HCT MRD dynamics. Day +100 landmark analysis of (A) risk of relapse, (B) RFS, (C) OS, and (D) risk of NRM, shown for the entire study cohort.